Viewing nowCombinationRosuvastatin/Amlodipine Tablet 20/5 mg
Rosuvastatin Calcium 20.8mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 201803561 · Approved 2018.08.31 · Insurance code 642105220
Improvement of dyslipidemia; treatment of hypertension and angina; reduction of cardiovascular risk and inhibition of atherosclerosis
This medication is used only for patients who require simultaneous administration of two drugs, amlodipine and rosuvastatin. Amlodipine is primarily used to treat hypertension and angina, especially ischemia due to coronary artery spasms or contractions. Additionally, it helps reduce the risk of hospitalization due to angina and the risk related to vascular interventions in patients with coronary artery disease who do not have heart failure. In contrast, rosuvastatin is used as an adjunct when dietary and exercise controls are insufficient for treating dyslipidemia such as hypercholesterolemia and mixed dyslipidemia. This medication effectively lowers cholesterol, slows the progression of atherosclerosis, and reduces the risk of cardiovascular disease, particularly helping to decrease the risks associated with stroke, myocardial infarction, and vascular revascularization. Therefore, this medication is used to improve cardiovascular health by managing blood pressure and lipid levels.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and rosuvastatin. ○ Amlodipine Adults: Administer 5 mg of amlodipine orally once daily; the dose may be increased to a maximum of 10 mg daily according to the patient's response. Adjust the dose as appropriate according to symptoms. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients. Patients taking amlodipine and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.
This medication should not be used by patients who are allergic to its components or similar types of medication. Women who are pregnant, may become pregnant, do not employ adequate contraceptives, or are breastfeeding should not use this medication and should consult a physician if necessary. Patients with severely impaired liver function, unexplained increased liver enzyme levels, or active liver disease should not take this medication. Patients with heart valve disease, in shock, or with muscle disorders, as well as those taking specific immunosuppressants, should also not use this medication. Patients with severely reduced kidney function (especially those with a creatinine clearance of less than 30 mL/min) are prohibited from using this medication. Patients at high risk of muscle disorder should especially avoid high doses of this medication, including those with kidney impairment, hypothyroidism, a family history of muscle disorders, alcoholism, Asians, and interactions with other specific medications. Patients with severe hypotension, those undergoing dialysis, elderly patients, and those with symptoms of muscle weakness should use this medication cautiously, regularly checking liver function and muscle-related symptoms. If symptoms such as muscle pain, weakness, cramps, fatigue, or fever occur while taking this medication, notify a physician immediately and stop the medication if necessary. This medication may affect liver function, so patients with a history of liver disease should be particularly careful and regularly monitor liver enzyme levels. This medication can rarely cause allergic reactions such as skin rashes, hives, and severe skin reactions, so consult medical staff immediately if any skin symptoms appear. Pregnant or breastfeeding women should refrain from using this medication to protect the health of the fetus and baby, and women planning to become pregnant should use proper contraceptive methods. The safety and efficacy of this medication have not been established in children; it is advisable not to use it in pediatric patients. In case of overdose, severe hypotension or cardiac problems may occur, requiring immediate medical treatment; as there is no specific antidote, symptomatic treatment will be necessary. This medication should be kept out of reach of children, stored in its original container, to prevent misuse or quality deterioration.
Peripheral edema, chest pain, wrist fracture, gout, dizziness, headache, constipation, dental fracture, dysuria, vascular edema, hypersensitivity reaction, diabetes, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myasthenia gravis, ocular myasthenia, ALT increase, AST increase, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, fainting, generalized pain, muscle cramps, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 degree and 30 degrees.
Orange round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 10.4mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 5.2mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Yuhan Corporation
Rosuvastatin Calcium 5.2mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 10.4mg · Amlodipine Besylate 13.889mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationRosuvastatin Calcium 5.2mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.